Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib for Moderate to Severe Plaque Psoriasis Phase II Trial
CTR20202165Phase 2Completed
- Sponsor
- Suzhou Zelgen Biopharmaceuticals
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in psoriasis, sponsored by Suzhou Zelgen Biopharmaceuticals. Started Nov 2020; status: completed.
02
Drugs
jaktinib
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20202165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202165.